Colgate-Palmolive Company $CL Shares Purchased by Evernest Financial Advisors LLC

Evernest Financial Advisors LLC raised its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 24.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,696 shares of the company’s stock after buying an additional 727 shares during the period. Evernest Financial Advisors LLC’s holdings in Colgate-Palmolive were worth $336,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Turtle Creek Wealth Advisors LLC acquired a new position in Colgate-Palmolive during the second quarter valued at approximately $337,000. Rosenberg Matthew Hamilton lifted its position in shares of Colgate-Palmolive by 79.8% during the second quarter. Rosenberg Matthew Hamilton now owns 3,110 shares of the company’s stock worth $283,000 after purchasing an additional 1,380 shares in the last quarter. Mutual Advisors LLC lifted its position in shares of Colgate-Palmolive by 5.1% during the second quarter. Mutual Advisors LLC now owns 8,265 shares of the company’s stock worth $727,000 after purchasing an additional 401 shares in the last quarter. Generali Asset Management SPA SGR lifted its position in shares of Colgate-Palmolive by 54.9% during the second quarter. Generali Asset Management SPA SGR now owns 101,806 shares of the company’s stock worth $9,254,000 after purchasing an additional 36,072 shares in the last quarter. Finally, Ritholtz Wealth Management lifted its position in shares of Colgate-Palmolive by 5.8% during the second quarter. Ritholtz Wealth Management now owns 65,175 shares of the company’s stock worth $5,924,000 after purchasing an additional 3,544 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 0.9%

Shares of NYSE:CL opened at $77.67 on Thursday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company has a fifty day simple moving average of $82.20 and a 200 day simple moving average of $87.60. The firm has a market cap of $62.77 billion, a PE ratio of 21.82, a price-to-earnings-growth ratio of 4.60 and a beta of 0.34. Colgate-Palmolive Company has a 12-month low of $76.68 and a 12-month high of $101.89.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive’s payout ratio is presently 58.43%.

Analyst Ratings Changes

A number of research analysts have recently commented on CL shares. JPMorgan Chase & Co. reduced their target price on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. UBS Group reduced their target price on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research note on Thursday, September 25th. Finally, Barclays dropped their price target on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $92.21.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.